During the past decade, Cape Breton Cancer Centre conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cape Breton Cancer Centre" #1 sponsor was "AGO Study Group" with 1 trials, followed by "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "NCIC Clinical Trials Group" with 1 trials sponsored and "Purdue Pharma, Canada" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cape Breton Cancer Centre" #1 collaborator was "NCIC Clinical Trials Group" with 4 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "Central European Cooperative Oncology Group" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Cape Breton Cancer Centre" are "Bladder Cancer" (1 trials), "Breast Cancer" (1 trials), "Chemotherapy-Induced Nausea and Vomiting" (1 trials), "Colorectal Cancer" (1 trials) and "Multiple Myeloma and Plasma Cell Neoplasm" (1 trials). Many other conditions were trialed in "Cape Breton Cancer Centre" in a lesser frequency.

Most popular intervention types in "Cape Breton Cancer Centre" are "Drug" (5 trials), "Genetic" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "gemcitabine hydrochloride" (2 trials), "300mg netupitant/0.5mg palonosetron hydrochloride" (1 trials), "DNA stability analysis" (1 trials), "adjuvant therapy" (1 trials) and "carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cape Breton Cancer Centre" are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Cape Breton Cancer Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Cape Breton Cancer Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cape Breton Cancer Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".